Cardiovascular Magnetic Resonance Imaging and Heart Failure

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2021 Mar 9

PMID 33686516

Citations 12

Authors

Chuanfen Liu

Victor A Ferrari

Yuchi Han

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The purpose of this review is to summarize the application of cardiac magnetic resonance (CMR) in the diagnostic and prognostic evaluation of patients with heart failure (HF).

Recent Findings: CMR is an important non-invasive imaging modality in the assessment of ventricular volumes and function and in the analysis of myocardial tissue characteristics. The information derived from CMR provides a comprehensive evaluation of HF. Its unique ability of tissue characterization not only helps to reveal the underlying etiologies of HF but also offers incremental prognostic information. CMR is a useful non-invasive tool for the diagnosis and assessment of prognosis in patients suffering from heart failure.

Citing Articles

Radiomics for differential diagnosis of ischemic and dilated cardiomyopathy using non-contrast-enhanced cine cardiac magnetic resonance imaging.

Lasode J, Chantaksinopas W, Khongwirotphan S, Chattranukulchai P, Vorasettakarnkij Y, Sriswasdi S Radiol Med. 2025; .

PMID: 40063167 DOI: 10.1007/s11547-025-01979-z.

Investigating the Use of Generative Adversarial Networks-Based Deep Learning for Reducing Motion Artifacts in Cardiac Magnetic Resonance.

Ma Z, Zhu Y, Zhang X, Zhao Y, Zheng W, Yuan S J Multidiscip Healthc. 2025; 18:787-799.

PMID: 39963324 PMC: 11830935. DOI: 10.2147/JMDH.S492163.

Evaluation of the prognostic value of lateral MAPSE in patients with suspected coronary artery disease.

Yan C, Chang Y, FangWu , Yang M, Dai S, Zhang J Int J Cardiol Heart Vasc. 2024; 56:101567.

PMID: 39691829 PMC: 11650132. DOI: 10.1016/j.ijcha.2024.101567.

The Importance of Cardiac Magnetic Resonance in the Assessment Risk of Cardiac Arrhythmias in Patients with Arterial Hypertension.

Wysocki A, Macek P, Dziadkowiec-Macek B, Poreba M, Gac P, Poreba R J Clin Med. 2024; 13(18).

PMID: 39336870 PMC: 11432360. DOI: 10.3390/jcm13185383.

Non-invasive in vivo imaging of changes in Collagen III turnover in myocardial fibrosis.

Chaher N, Lacerda S, Digilio G, Padovan S, Gao L, Lavin B Npj Imaging. 2024; 2(1):33.

PMID: 39301014 PMC: 11408249. DOI: 10.1038/s44303-024-00037-z.

References

Weng Z, Yao J, Chan R, He J, Yang X, Zhou Y . Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. JACC Cardiovasc Imaging. 2016; 9(12):1392-1402. DOI: 10.1016/j.jcmg.2016.02.031. View

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

Gulati A, Japp A, Raza S, Halliday B, Jones D, Newsome S . Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure. Circ Cardiovasc Imaging. 2018; 11(9):e007722. DOI: 10.1161/CIRCIMAGING.118.007722. View

Dungu J, Valencia O, Pinney J, Gibbs S, Rowczenio D, Gilbertson J . CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014; 7(2):133-42. DOI: 10.1016/j.jcmg.2013.08.015. View

Edwards N, Moody W, Yuan M, Weale P, Neal D, Townend J . Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation. Circ Cardiovasc Imaging. 2014; 7(6):946-53. DOI: 10.1161/CIRCIMAGING.114.002397. View

Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zagrosek A, Dietz R . Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol. 2009; 53(3):284-91. DOI: 10.1016/j.jacc.2008.08.064. View

Marie P, Angioi M, Carteaux J, Escanye J, Mattei S, Tzvetanov K . Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol. 2001; 37(3):825-31. DOI: 10.1016/s0735-1097(00)01196-7. View

Becker M, Cornel J, van de Ven P, van Rossum A, Allaart C, Germans T . The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. JACC Cardiovasc Imaging. 2018; 11(9):1274-1284. DOI: 10.1016/j.jcmg.2018.03.006. View

von Knobelsdorff-Brenkenhoff F, Schuler J, Doganguzel S, Dieringer M, Rudolph A, Greiser A . Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance. Circ Cardiovasc Imaging. 2017; 10(2). DOI: 10.1161/CIRCIMAGING.116.005242. View

10.

El Aidi H, Adams A, Moons K, den Ruijter H, Mali W, Doevendans P . Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol. 2014; 63(11):1031-45. DOI: 10.1016/j.jacc.2013.11.048. View

11.

Marcus F, McKenna W, Sherrill D, Basso C, Bauce B, Bluemke D . Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010; 121(13):1533-41. PMC: 2860804. DOI: 10.1161/CIRCULATIONAHA.108.840827. View

12.

Lurz P, Luecke C, Eitel I, Fohrenbach F, Frank C, Grothoff M . Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. J Am Coll Cardiol. 2016; 67(15):1800-1811. DOI: 10.1016/j.jacc.2016.02.013. View

13.

Bondue A, Arbustini E, Bianco A, Ciccarelli M, Dawson D, De Rosa M . Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology. Cardiovasc Res. 2018; 114(10):1287-1303. PMC: 6054212. DOI: 10.1093/cvr/cvy122. View

14.

McCrohon J, Moon J, Prasad S, McKenna W, Lorenz C, Coats A . Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003; 108(1):54-9. DOI: 10.1161/01.CIR.0000078641.19365.4C. View

15.

Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu C . T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. 2015; 8(12). DOI: 10.1161/CIRCIMAGING.115.003285. View

16.

Halliday B, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M . Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction. Circulation. 2017; 135(22):2106-2115. PMC: 5444425. DOI: 10.1161/CIRCULATIONAHA.116.026910. View

17.

Amzulescu M, Rousseau M, Ahn S, Boileau L, De Meester de Ravenstein C, Vancraeynest D . Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study. JACC Cardiovasc Imaging. 2015; 8(8):934-46. DOI: 10.1016/j.jcmg.2015.04.015. View

18.

Swoboda P, McDiarmid A, Erhayiem B, Broadbent D, Dobson L, Garg P . Assessing Myocardial Extracellular Volume by T1 Mapping to Distinguish Hypertrophic Cardiomyopathy From Athlete's Heart. J Am Coll Cardiol. 2016; 67(18):2189-2190. DOI: 10.1016/j.jacc.2016.02.054. View

19.

Grani C, Eichhorn C, Biere L, Murthy V, Agarwal V, Kaneko K . Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol. 2017; 70(16):1964-1976. PMC: 6506846. DOI: 10.1016/j.jacc.2017.08.050. View

20.

Mrsic Z, Mousavi N, Hulten E, Bittencourt M . The Prognostic Value of Late Gadolinium Enhancement in Nonischemic Heart Disease. Magn Reson Imaging Clin N Am. 2019; 27(3):545-561. DOI: 10.1016/j.mric.2019.04.010. View